Cargando…
Retracted: The Clinical Efficacy and Economic Benefits of Recombinant Human Thrombopoietin for the Treatment of Chemotherapy or Chemoradiotherapy-Induced Thrombocytopenia
Autor principal: | Imaging, Contrast Media & Molecular |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371756/ https://www.ncbi.nlm.nih.gov/pubmed/37502537 http://dx.doi.org/10.1155/2023/9783232 |
Ejemplares similares
-
Retracted: Related Factors and Economic Burden Evaluation of Nosocomial Infection in Patients with Chronic Kidney Disease
por: Imaging, Contrast Media & Molecular
Publicado: (2023) -
Retracted: Meta-Analysis of the Effect of Dietary Care on Nausea and Vomiting in Oncology Chemotherapy Patients
por: Imaging, Contrast Media & Molecular
Publicado: (2023) -
Retracted: Study on Huangqi Bazhen Decoction on Relieving Chemotherapy Intestinal Mucositis in Capecitabine Gavage Mice
por: Imaging, Contrast Media & Molecular
Publicado: (2023) -
Retracted: Meta-Analysis of Anesthetic Efficacy and Safety of Propofol in Craniotomy Patients
por: Imaging, Contrast Media & Molecular
Publicado: (2023) -
Retracted: The Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol in the Treatment of COPD in the Elderly
por: Imaging, Contrast Media & Molecular
Publicado: (2023)